Your browser is no longer supported. Please, upgrade your browser.
KYMR [NASD]
Kymera Therapeutics, Inc.
Index- P/E- EPS (ttm)-1.30 Insider Own12.20% Shs Outstand45.09M Perf Week-2.16%
Market Cap2.68B Forward P/E- EPS next Y-2.15 Insider Trans-3.98% Shs Float28.30M Perf Month-11.83%
Income-58.40M PEG- EPS next Q-0.42 Inst Own68.20% Short Float5.81% Perf Quarter-8.45%
Sales64.50M P/S41.62 EPS this Y-28.50% Inst Trans2.15% Short Ratio4.89 Perf Half Y34.69%
Book/sh5.72 P/B9.18 EPS next Y-29.40% ROA-12.30% Target Price76.29 Perf Year37.98%
Cash/sh7.03 P/C7.48 EPS next 5Y-14.90% ROE-21.00% 52W Range29.93 - 91.92 Perf YTD-15.27%
Dividend- P/FCF49.99 EPS past 5Y- ROI-16.20% 52W High-40.24% Beta-
Dividend %- Quick Ratio3.40 Sales past 5Y- Gross Margin- 52W Low83.56% ATR3.22
Employees112 Current Ratio3.40 Sales Q/Q176.10% Oper. Margin-91.10% RSI (14)44.24 Volatility5.71% 5.34%
OptionableYes Debt/Eq0.01 EPS Q/Q30.60% Profit Margin-90.50% Rel Volume0.58 Prev Close52.53
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume336.77K Price54.93
Recom2.10 SMA20-5.74% SMA50-6.54% SMA2001.81% Volume51,601 Change4.57%
Sep-30-21Initiated Stifel Buy $80
Sep-30-21Initiated B. Riley Securities Neutral $67
Sep-10-21Downgrade BofA Securities Buy → Neutral $65 → $80
May-21-21Initiated UBS Buy $80
Apr-14-21Initiated Berenberg Buy
Dec-04-20Initiated H.C. Wainwright Buy $85
Sep-15-20Initiated Morgan Stanley Equal-Weight $27
Sep-15-20Initiated Guggenheim Buy $42
Sep-15-20Initiated Cowen Outperform
Sep-15-20Initiated BofA Securities Neutral $35
Oct-20-21 08:00AM  
Oct-13-21 07:00AM  
Sep-16-21 01:43PM  
Sep-02-21 08:00AM  
Aug-08-21 03:37AM  
Aug-06-21 07:00AM  
Jul-29-21 07:00AM  
Jul-28-21 03:45PM  
Jul-12-21 08:00AM  
Jul-06-21 04:00PM  
Jun-30-21 09:45PM  
Jun-29-21 09:34AM  
08:56AM  
Jun-28-21 04:36PM  
08:55AM  
06:00AM  
Jun-21-21 04:00PM  
11:20AM  
08:00AM  
Jun-09-21 08:00AM  
Jun-02-21 04:00PM  
May-26-21 09:00AM  
May-19-21 01:36AM  
May-10-21 09:00AM  
May-08-21 04:06AM  
May-06-21 07:00AM  
May-05-21 07:00AM  
May-04-21 07:00AM  
May-03-21 04:00PM  
08:00AM  
Apr-19-21 07:30AM  
Apr-10-21 08:30AM  
Apr-09-21 07:30AM  
Mar-16-21 04:01PM  
Mar-11-21 07:00AM  
Mar-02-21 07:00AM  
Feb-25-21 07:00AM  
Feb-04-21 07:00AM  
Feb-03-21 07:00AM  
Jan-12-21 07:00AM  
Jan-05-21 04:01PM  
Dec-19-20 07:24PM  
Dec-16-20 07:00AM  
Dec-07-20 10:00AM  
Nov-26-20 12:22AM  
Nov-23-20 08:00AM  
Nov-21-20 03:15AM  
Nov-11-20 08:00AM  
Nov-05-20 07:00AM  
Nov-04-20 10:01AM  
Oct-12-20 07:00AM  
04:19AM  
Oct-09-20 07:00AM  
Sep-14-20 07:00AM  
Sep-09-20 07:00AM  
Aug-27-20 07:00AM  
Aug-25-20 04:01PM  
Aug-20-20 08:36PM  
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunology-inflammation diseases, including hidradenitis suppurativa, atopic dermatitis, and rheumatoid arthritis; IRAKIMiD program to treat MYD88-mutated diffuse large B cell lymphoma; and STAT3 program for the treatment of hematologic malignancies and solid tumors, as well as autoimmune diseases. The company was founded in 2015 and is headquartered in Watertown, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Mainolfi NelloChief Executive OfficerOct 11Option Exercise2.086,45613,428470,655Oct 12 04:30 PM
Mainolfi NelloChief Executive OfficerOct 11Sale53.686,456346,590464,199Oct 12 04:30 PM
Mainolfi NelloChief Executive OfficerOct 08Option Exercise2.0841,54486,412505,743Oct 12 04:30 PM
Mainolfi NelloChief Executive OfficerOct 08Sale56.7641,5442,357,946464,199Oct 12 04:30 PM
Jacobs Bruce N.Chief Financial OfficerSep 03Sale60.1210,000601,1807,256Sep 03 05:57 PM
Chesworth RichardChief Scientific OfficerAug 27Option Exercise20.0033,779675,58033,779Aug 27 04:55 PM
Chesworth RichardChief Scientific OfficerAug 27Sale60.1233,7792,030,8640Aug 27 04:55 PM
Mainolfi NelloChief Executive OfficerAug 19Option Exercise2.0812,00024,960464,199Aug 19 04:30 PM
Chesworth RichardChief Scientific OfficerAug 17Option Exercise20.0054,0001,080,00054,000Aug 19 04:30 PM
Chesworth RichardChief Scientific OfficerAug 17Sale50.3754,0002,720,1820Aug 19 04:30 PM
Booth BruceDirectorAug 11Sale61.00242,13314,770,1130Aug 12 10:43 AM
ATLAS VENTURE ASSOCIATES X, L.10% OwnerAug 11Sale61.00242,13314,770,1130Aug 12 10:42 AM
Mainolfi NelloChief Executive OfficerAug 04Option Exercise2.081,0372,157453,236Aug 05 04:14 PM
Mainolfi NelloChief Executive OfficerAug 04Sale60.031,03762,253452,199Aug 05 04:14 PM
Mainolfi NelloChief Executive OfficerAug 03Option Exercise2.085,66911,792457,868Aug 05 04:14 PM
Mainolfi NelloChief Executive OfficerAug 03Sale60.075,669340,533452,199Aug 05 04:14 PM
Mainolfi NelloChief Executive OfficerAug 02Option Exercise2.0823,45648,788475,655Aug 02 05:53 PM
Mainolfi NelloChief Executive OfficerAug 02Sale60.3023,4561,414,404452,199Aug 02 05:53 PM
Mainolfi NelloChief Executive OfficerJul 30Option Exercise2.086,27913,060458,478Aug 02 05:53 PM
Mainolfi NelloChief Executive OfficerJul 30Sale60.076,279377,167452,199Aug 02 05:53 PM
Mainolfi NelloChief Executive OfficerJul 29Option Exercise2.086801,414452,879Aug 02 05:53 PM
Mainolfi NelloChief Executive OfficerJul 29Sale60.0068040,800452,199Aug 02 05:53 PM
Mainolfi NelloChief Executive OfficerJul 28Option Exercise2.083,8648,037456,063Jul 28 04:57 PM
Mainolfi NelloChief Executive OfficerJul 28Sale60.153,864232,410452,199Jul 28 04:57 PM
Mainolfi NelloChief Executive OfficerJul 26Option Exercise2.089,01518,751461,214Jul 28 04:57 PM
Mainolfi NelloChief Executive OfficerJul 26Sale60.159,015542,237452,199Jul 28 04:57 PM
Mainolfi NelloChief Executive OfficerJul 08Option Exercise2.0848,00099,840500,199Jul 09 04:30 PM
Mainolfi NelloChief Executive OfficerJul 08Sale49.7048,0002,385,628452,199Jul 09 04:30 PM
BVF PARTNERS L P/ILDirectorJul 01Buy47.00544,16625,575,8021,664,104Jul 06 06:40 PM
Mainolfi NelloChief Executive OfficerJun 14Option Exercise2.0840,00083,200452,199Jun 14 05:57 PM
Mainolfi NelloChief Executive OfficerJun 10Option Exercise2.0823,00947,859435,208Jun 11 04:15 PM
Mainolfi NelloChief Executive OfficerJun 10Sale51.3823,0091,182,106412,199Jun 11 04:15 PM
Mainolfi NelloChief Executive OfficerJun 09Option Exercise2.085,75211,964417,951Jun 09 05:54 PM
Mainolfi NelloChief Executive OfficerJun 09Sale50.025,752287,721412,199Jun 09 05:54 PM
Mainolfi NelloChief Executive OfficerJun 08Option Exercise2.08270562412,469Jun 09 05:54 PM
Mainolfi NelloChief Executive OfficerJun 08Sale50.0027013,500412,199Jun 09 05:54 PM
Mainolfi NelloChief Executive OfficerJun 07Option Exercise2.0812,72426,466424,923Jun 09 05:54 PM
Mainolfi NelloChief Executive OfficerJun 07Sale50.1412,724638,040412,199Jun 09 05:54 PM
Jacobs Bruce N.Chief Financial OfficerJun 03Option Exercise2.0810,00020,80017,256Jun 04 04:16 PM
Jacobs Bruce N.Chief Financial OfficerJun 03Sale46.8710,000468,6957,256Jun 04 04:16 PM
Mainolfi NelloChief Executive OfficerMay 19Option Exercise2.0815,00031,200412,199May 19 05:56 PM
Mainolfi NelloChief Executive OfficerMay 12Option Exercise2.088,24517,150405,444May 14 05:20 PM
Mainolfi NelloChief Executive OfficerMay 12Sale50.058,245412,677397,199May 14 05:20 PM
Mainolfi NelloChief Executive OfficerApr 26Option Exercise2.082,7685,757399,967Apr 26 05:15 PM
Mainolfi NelloChief Executive OfficerApr 26Sale40.182,768111,229397,199Apr 26 05:15 PM
Mainolfi NelloChief Executive OfficerApr 23Option Exercise2.086801,414397,879Apr 26 05:15 PM
Mainolfi NelloChief Executive OfficerApr 23Sale40.0168027,208397,199Apr 26 05:15 PM
Mainolfi NelloChief Executive OfficerApr 22Option Exercise2.0810,95922,795408,158Apr 26 05:15 PM
Mainolfi NelloChief Executive OfficerApr 22Sale40.2610,959441,182397,199Apr 26 05:15 PM
Mainolfi NelloChief Executive OfficerApr 19Option Exercise2.086,65313,838397,199Apr 19 07:12 PM
Mainolfi NelloChief Executive OfficerApr 19Sale40.0065326,121391,199Apr 19 07:12 PM
Mainolfi NelloChief Executive OfficerApr 15Option Exercise2.084,94010,275396,139Apr 19 07:12 PM
Mainolfi NelloChief Executive OfficerApr 15Sale40.294,940199,039391,199Apr 19 07:12 PM
Mainolfi NelloChief Executive OfficerApr 13Option Exercise2.0815,00031,200391,199Apr 13 06:39 PM
Jacobs Bruce N.Chief Financial OfficerApr 13Option Exercise2.087,00014,5607,000Apr 13 06:37 PM
Mainolfi NelloChief Executive OfficerApr 12Option Exercise2.0815,26731,755391,466Apr 12 06:11 PM
Mainolfi NelloChief Executive OfficerApr 12Sale32.6215,267497,981376,199Apr 12 06:11 PM
Mainolfi NelloChief Executive OfficerApr 09Option Exercise2.0822,79447,412398,993Apr 12 06:11 PM
Mainolfi NelloChief Executive OfficerApr 09Sale33.6822,794767,750376,199Apr 12 06:11 PM
Mainolfi NelloChief Executive OfficerApr 08Option Exercise2.089,93920,673386,138Apr 12 06:11 PM
Mainolfi NelloChief Executive OfficerApr 08Sale35.009,939347,832376,199Apr 12 06:11 PM
Jacobs Bruce N.Chief Financial OfficerMar 15Option Exercise2.088,19517,0468,195Mar 15 09:08 PM
Gollob JaredChief Medical OfficerMar 15Option Exercise1.317,80010,21852,852Mar 15 09:12 PM
Gollob JaredChief Medical OfficerMar 15Sale60.1710,305620,05242,547Mar 15 09:12 PM
Jacobs Bruce N.Chief Financial OfficerMar 15Sale60.178,195493,0960Mar 15 09:08 PM
Booth BruceDirectorMar 12Sale56.50229,35012,958,2750Mar 16 07:39 PM
ATLAS VENTURE ASSOCIATES X, L.10% OwnerMar 12Sale56.50229,35012,958,2750Mar 16 07:37 PM
Jacobs Bruce N.Chief Financial OfficerMar 11Option Exercise2.081,8053,7541,805Mar 15 09:08 PM
Gollob JaredChief Medical OfficerMar 11Option Exercise1.312,2002,88249,747Mar 15 09:12 PM
Gollob JaredChief Medical OfficerMar 11Sale60.054,695281,93945,052Mar 15 09:12 PM
Jacobs Bruce N.Chief Financial OfficerMar 11Sale60.071,805108,4320Mar 15 09:08 PM
Jacobs Bruce N.Chief Financial OfficerMar 08Option Exercise2.0810,00020,80010,000Mar 08 08:01 PM
Jacobs Bruce N.Chief Financial OfficerMar 08Sale50.6510,000506,4700Mar 08 08:01 PM
Jacobs Bruce N.Chief Financial OfficerMar 03Option Exercise2.0820,00041,60020,000Mar 05 05:26 PM
Jacobs Bruce N.Chief Financial OfficerMar 03Sale44.7820,000895,6340Mar 05 05:26 PM
Gollob JaredChief Medical OfficerFeb 24Sale50.918,675441,67147,547Feb 24 06:44 PM
Gollob JaredChief Medical OfficerFeb 23Sale49.6519,285957,55456,222Feb 24 06:44 PM
Gollob JaredChief Medical OfficerFeb 22Sale52.639,104479,13075,507Feb 24 06:44 PM
Gollob JaredChief Medical OfficerFeb 19Sale55.098,887489,55984,611Feb 19 07:27 PM
Gollob JaredChief Medical OfficerFeb 18Sale55.946,499363,54093,498Feb 19 07:27 PM
Gollob JaredChief Medical OfficerFeb 17Sale58.397,550440,83699,997Feb 19 07:27 PM